A Silent Threat to Mothers and Babies
Understanding Preeclampsia
Preeclampsia is a serious pregnancy complication characterized by high blood pressure and organ dysfunction, typically occurring after 20 weeks of gestation. It remains one of the leading causes of maternal and neonatal morbidity and mortality.
Access to practical preeclampsia screening remains limited, leaving many mothers without reliable diagnostic support.
Expanding access to simple and scalable testing could significantly improve maternal care worldwide.
A Growing Clinical Burden
-
United States: Affects ~5–8% of pregnancies, impacting over 200,000 annually.
-
Worldwide: Over 8 million pregnancies complicated by preeclampsia each year.
-
Mortality: Contributes to ~76,000 maternal and 500,000 infant deaths globally every year.
Translating Clinical Discovery into Real-World Diagnostics
Working alongside clinical collaborators at the Mayo Clinic, we are translating novel urinary biomarker discoveries into a next-generation diagnostic platform for preeclampsia screening.
Clinical Barrier
• Limited access to testing
• Laboratory-dependent workflows
• Complex diagnostics
Our Solutions
• Urine-based detection
• Rapid electrochemical sensing
• Practical clinical deployment
Learn More About Preeclampsia
These resources provide additional clinical context and educational information about preeclampsia and maternal health.
- Centers for Disease Control and Prevention – Overview of preeclampsia, risk factors, and maternal health data
- World Health Organization – Global impact of hypertensive disorders in pregnancy
- Mayo Clinic – Clinical explanation of symptoms, diagnosis, and treatment options